AbbVie (NYSE:ABBV) reported quarterly earnings of $3.65 per share which beat the analyst consensus estimate of $3.60 by 1.39 percent. This is a 22.9 percent increase over earnings of $2.97 per share from the same period last year. The company reported quarterly sales of $16.990 billion which beat the analyst consensus estimate of $16.765 billion by 1.34 percent. This is a 10.16 percent increase over sales of $15.423 billion the same period last year.